The Department of Health and Social Care and MHRA are amending the Human Medicines Regulations through draft regulations and consultation on changes to health service product information disclosure rules, aimed at benefiting NHS patients and British businesses through modernised medicines access procedures. The amendments represent significant changes to the regulatory framework governing medicines approval and provision.
Seeks views on proposed amendments to the Health Service Products (Provision and Disclosure of Information) Regulations 2018.
In response to: Using dual energy x-ray absorptiometry (DEXA) scans for non-medical purposes as a justifi…
We are seeking views on the potential use of DEXA scans outside of a healthcare pathway.
In response to: Proposed changes to the health service products information regulations 2018
Seeks views on proposed amendments to the Health Service Products (Provision and Disclosure of Information) Regulations 2018.
In response to: Amend regulations to support the supply and deployment of vaccines
In response to: Amend regulations to support the supply and deployment of vaccines
This consultation seeks views on amending the Human Medicines Regulations 2012 to support the ongoing supply and deployment of vaccinations across the UK.
This consultation seeks views on proposals to enable pharmacist flexibilities when dispensing medicines.
This consultation seeks views on amending the Human Medicines Regulations 2012 to support the ongoing supply and deployment of vaccinations across the UK.
This consultation seeks views on extending medicines responsibilities for paramedics, physiotherapists, operating department practitioners and diagnostic radiographers.
This consultation seeks views on proposals to enable pharmacist flexibilities when dispensing medicines.
This consultation seeks views on amending the Human Medicines Regulations 2012 to support the ongoing supply and deployment of vaccinations across the UK.
In response to: Extend medicines for optometrists and contact lens opticians
This consultation seeks views on extending medicines responsibilities for paramedics, physiotherapists, operating department practitioners and diagnostic radiographers.
In response to: Extend medicines responsibilities for allied health professions
DHSC is seeking views on proposals to modernise legislation governing the supervision of activities by a pharmacist in a pharmacy.
In response to: Health Protection (Notification) Regulations 2010: proposed amendments
This consultation seeks views on proposed amendments to the Health Protection (Notification) Regulations 2010 (HPNR).
In response to: Amending references to PHE and HSCB in the Human Medicines Regulations
In response to: Amending references to PHE and HSCB in the Human Medicines Regulations
We are seeking views about making amendments to references to Public Health England and the Regional Health and Social Care Board within the Human Medicines Regulations 2012.
This consultation will inform the government’s proposal to enable pharmacy technicians to supply and administer medicines using patient group directions.
DHSC is seeking views on proposals to modernise legislation governing the supervision of activities by a pharmacist in a pharmacy.
We are seeking views about making amendments to references to Public Health England and the Regional Health and Social Care Board within the Human Medicines Regulations 2012.
We are seeking views about making amendments to references to Public Health England and the Regional Health and Social Care Board within the Human Medicines Regulations 2012.
This is a consultation on a statutory instrument to amend the Human Medicines Regulations 2012 to remove the provision which provides the legal basis to the European Commission Decision Reliance Procedure (ECDRP).
DHSC is seeking views on proposals to modernise legislation governing the supervision of activities by a pharmacist in a pharmacy.
This consultation seeks views on proposed amendments to the Health Protection (Notification) Regulations 2010 (HPNR).
This consultation will inform the government’s proposal to enable pharmacy technicians to supply and administer medicines using patient group directions.
This is a consultation on a statutory instrument to amend the Human Medicines Regulations 2012 to remove the provision which provides the legal basis to the European Commission Decision Reliance Procedure (ECDRP).
This is a consultation on a statutory instrument to amend the Human Medicines Regulations 2012 to remove the provision which provides the legal basis to the European Commission Decision Reliance Procedure (ECDRP).
This consultation will inform the government’s proposal to enable pharmacy technicians to supply and administer medicines using patient group directions.
This consultation seeks views on proposed amendments to the Health Protection (Notification) Regulations 2010 (HPNR).
Public consultation on proposals to allow pharmacists to dispense prescription medicines in original packaging, in particular those containing sodium valproate.
In response to: Point of Care Consultation
In response to: The future strategy for batch testing of medicinal products in Great Britain
In response to: The future strategy for batch testing of medicinal products in Great Britain
We want your views on 4 proposed options for a future policy on batch testing of medicines for Great Britain.
We want your views on 4 proposed options for a future policy on batch testing of medicines for Great Britain.
We want your views on 4 proposed options for a future policy on batch testing of medicines for Great Britain.
In response to: Pharmacy legislation on dispensing errors and organisational governance
Seeks views on proposals for 2 draft orders which would amend current pharmacy legislation on dispensing errors and clarify how registered pharmacies are governed.
In response to: Tobacco and related products legislation introduced between 2015 and 2016: reviewing effe…
In response to: Early Access to Medicines Scheme (EAMS) Consultation
We're looking for your views and comments on our proposed legislative changes to clarify the legal basis for EAMS.
In response to: Review of temporary provisions in the Human Medicines Regulations 2012 to support influen…
In response to: Review of temporary provisions in the Human Medicines Regulations 2012 to support influen…
We would like your views on a review of temporary provisions in the Human Medicines Regulations to support influenza and COVID-19 vaccination campaigns.
We would like your views on a review of temporary provisions in the Human Medicines Regulations to support influenza and COVID-19 vaccination campaigns.
Public consultation on proposals to allow pharmacists to dispense prescription medicines in original packaging, in particular those containing sodium valproate.
We would like your views on a review of temporary provisions in the Human Medicines Regulations to support influenza and COVID-19 vaccination campaigns.
Seeks views on proposed changes to the Human Medicines Regulations and the Medicines Act.
Public consultation on proposals to allow pharmacists to dispense prescription medicines in original packaging, in particular those containing sodium valproate.
We're looking for your views and comments on our proposed legislative changes to clarify the legal basis for EAMS.
We're looking for your views and comments on our proposed legislative changes to clarify the legal basis for EAMS.
Expert Working Group concludes there is currently insufficient evidence to establish a link between use of ibuprofen and susceptibility to contracting COVID-19 or the worsening of its symptoms.
There is no evidence from clinical or epidemiological studies that treatment with ACE-I or ARBs might worsen COVID-19 infection.
This consultation seeks your views on how the Medicines and Healthcare products Regulatory Agency’s (MHRA) legislation and regulatory processes would have to be modified in the event of the UK not securing a deal with the EU after the UK’s …
This consultation invites views on the proposed steps we intend to take to make sure the UK meets its obligations to transpose the 'safety features' provisions of the Falsified Medicines Directive (FMD).
This consultation seeks your views on how the Medicines and Healthcare products Regulatory Agency’s (MHRA) legislation and regulatory processes would have to be modified in the event of the UK not securing a deal with the EU after the UK’s …
This consultation seeks your views on how the Medicines and Healthcare products Regulatory Agency’s (MHRA) legislation and regulatory processes would have to be modified in the event of the UK not securing a deal with the EU after the UK’s …
This consultation invites views on the proposed steps we intend to take to make sure the UK meets its obligations to transpose the 'safety features' provisions of the Falsified Medicines Directive (FMD).
Seeks views on proposals for 2 draft orders which would amend current pharmacy legislation on dispensing errors and clarify how registered pharmacies are governed.
This consultation invites views on the proposed steps we intend to take to make sure the UK meets its obligations to transpose the 'safety features' provisions of the Falsified Medicines Directive (FMD).
Seeks views on proposals for 2 draft orders which would amend current pharmacy legislation on dispensing errors and clarify how registered pharmacies are governed.
We are reviewing the impact of the Human Medicines Regulations 2012 (‘the 2012 Regulations’). This is part of a wider exercise within government to test the impact of legislation five years after implementation.
Seeks views on proposals for changes to the legislation on dispensing errors and registered pharmacy standards and other related matters.
We are reviewing the impact of the Human Medicines Regulations 2012 (‘the 2012 Regulations’). This is part of a wider exercise within government to test the impact of legislation five years after implementation.
We are reviewing the impact of the Human Medicines Regulations 2012 (‘the 2012 Regulations’). This is part of a wider exercise within government to test the impact of legislation five years after implementation.
Seeks views on draft regulations on implementing the revised EU Tobacco Products Directive (2014/40/EU).
Seeks views on proposed changes to the Human Medicines Regulations and the Medicines Act.
Seeks views on proposed changes to the Human Medicines Regulations and the Medicines Act.
Seeks views on draft regulations on implementing the revised EU Tobacco Products Directive (2014/40/EU).
Seeks views on the role and performance of the Medicines and Healthcare Products Regulatory Agency (MHRA)
Seeks views on draft regulations on implementing the revised EU Tobacco Products Directive (2014/40/EU).
Seeks views on proposals for changes to the legislation on dispensing errors and registered pharmacy standards and other related matters.
Seeks views on the role and performance of the Commission on Human Medicines (CHM)
Seeks views on proposals for changes to the legislation on dispensing errors and registered pharmacy standards and other related matters.
Seeks views on proposals to amend the Human Medicines Regulations 2012 so that PHE can develop and authorise Patient Group Directions.
Seeks views on the role and performance of the Commission on Human Medicines (CHM)
Seeks views on the role and performance of the Medicines and Healthcare Products Regulatory Agency (MHRA)
Seeks views on the role and performance of the Commission on Human Medicines (CHM)
Seeks views on the role and performance of the Medicines and Healthcare Products Regulatory Agency (MHRA)
Seeks views on proposals to amend the Human Medicines Regulations 2012 so that PHE can develop and authorise Patient Group Directions.
Seeks views on proposals to amend the Human Medicines Regulations 2012 so that PHE can develop and authorise Patient Group Directions.
This consultation welcomes views on proposals to allow paramedics involved in maritime and coastguard agency contracted helicopter search and rescue operations to use medicines under patient group directions.
This consultation welcomes views on proposals to allow paramedics involved in maritime and coastguard agency contracted helicopter search and rescue operations to use medicines under patient group directions.